Literature DB >> 20954865

The relative abundance of deer mice with antibody to Sin Nombre virus corresponds to the occurrence of hantavirus pulmonary syndrome in nearby humans.

Charles H Calisher1, James N Mills, Jon Jeffrey Root, Jeffrey B Doty, Barry J Beaty.   

Abstract

Sin Nombre virus (SNV) is the principal cause of hantavirus pulmonary syndrome (HPS) in the United States and deer mice (Peromyscus maniculatus) are its principal rodent host, and thus the natural cycle of the virus is related to the occurrence of HPS. Prevalence of rodent infection appears to be associated with fluctuations in deer mouse populations and, indirectly, with timing and amount of precipitation, a complex of biologic events. Given that rodent population abundances fluctuate, often acutely, it is not unreasonable to assume a direct correlation between the numbers of infected rodents and the number of human infections, unless confounding factors are involved. During a 13-year longitudinal study at a site in southwestern Colorado, we accumulated data regarding deer mice and antibody to SNV and therefore had the opportunity to compare dynamics of deer mouse populations, seroprevalence of antibody to SNV in the rodents, and numbers of HPS cases in Durango and in the State of Colorado as a whole. If abundances of deer mouse populations are directly correlated with occurrence of HPS, it is reasonable to assume that low densities of deer mice and low prevalences of antibody to SNV would lead to fewer human cases than would high densities and high prevalences. Our results substantiate such an assumption and suggest that the risk of acquisition of HPS is likely related to both high numbers of infected deer mice and human activities, rather than being strictly related to prevalence of SNV in the host rodent.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20954865     DOI: 10.1089/vbz.2010.0122

Source DB:  PubMed          Journal:  Vector Borne Zoonotic Dis        ISSN: 1530-3667            Impact factor:   2.133


  7 in total

Review 1.  Global Diversity and Distribution of Hantaviruses and Their Hosts.

Authors:  Matthew T Milholland; Iván Castro-Arellano; Gerardo Suzán; Gabriel E Garcia-Peña; Thomas E Lee; Rodney E Rohde; A Alonso Aguirre; James N Mills
Journal:  Ecohealth       Date:  2018-04-30       Impact factor: 3.184

2.  Exotic Pinus radiata Plantations do not Increase Andes Hantavirus Prevalence in Rodents.

Authors:  André V Rubio; Fernando Fredes; Javier A Simonetti
Journal:  Ecohealth       Date:  2019-10-25       Impact factor: 3.184

3.  The Ecology and Phylogeny of Hosts Drive the Enzootic Infection Cycles of Hantaviruses.

Authors:  Matthew T Milholland; Iván Castro-Arellano; Gabriel E Garcia-Peña; James N Mills
Journal:  Viruses       Date:  2019-07-23       Impact factor: 5.048

4.  The major cellular sterol regulatory pathway is required for Andes virus infection.

Authors:  Josiah Petersen; Mary Jane Drake; Emily A Bruce; Amber M Riblett; Chukwuka A Didigu; Craig B Wilen; Nirav Malani; Frances Male; Fang-Hua Lee; Frederic D Bushman; Sara Cherry; Robert W Doms; Paul Bates; Kenneth Briley
Journal:  PLoS Pathog       Date:  2014-02-06       Impact factor: 6.823

5.  Temporal dynamics of Puumala hantavirus infection in cyclic populations of bank voles.

Authors:  Liina Voutilainen; Eva R Kallio; Jukka Niemimaa; Olli Vapalahti; Heikki Henttonen
Journal:  Sci Rep       Date:  2016-02-18       Impact factor: 4.379

Review 6.  Viral Forecasting, Pathogen Cataloging, and Disease Ecosystem Mapping: Measuring Returns on Investments.

Authors:  Jeanne Fair; Joseph Fair
Journal:  Curr Top Microbiol Immunol       Date:  2019       Impact factor: 4.291

7.  Long-Term Rodent Surveillance after Outbreak of Hantavirus Infection, Yosemite National Park, California, USA, 2012.

Authors:  Mary E Danforth; Sharon Messenger; Danielle Buttke; Matthew Weinburke; George Carroll; Gregory Hacker; Michael Niemela; Elizabeth S Andrews; Bryan T Jackson; Vicki Kramer; Mark Novak
Journal:  Emerg Infect Dis       Date:  2020-03       Impact factor: 6.883

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.